NCT04429347 - Gabapentin and Tizanidine for Insomnia in Chronic Pain | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 29, 2020

Primary Completion Date

December 1, 2024

Study Completion Date

December 1, 2024

Conditions

Insomnia Due to Medical ConditionChronic Pain

Interventions

DRUG

Gabapentin

Friday night: 1 capsule of 300 mg, Saturday night: 2 capsule of 300 mg (total 600 mg), Sunday night: choice of 1 or 2 capsule of 300 mg (total of 300 or 600 mg)

DRUG

Placebo

Friday night: 1 capsule, Saturday night: 2 capsule, Sunday night: choice of 1 or 2 capsules

DRUG

Tizanidine

Friday night: 1 capsule of 2 mg, Saturday night: 2 capsule of 2 mg (total 4 mg), Sunday night: choice of 1 or 2 capsules of 2 mg (total of 2 or 4 mg)

Trial Locations (1)

92037

Center for Pain Medicine, UC San Diego, La Jolla

All Listed Sponsors

collaborator

National Center for Advancing Translational Sciences (NCATS)

NIH

lead

University of California, San Diego

OTHER